Shareholdings update

In brief · summary, not quotable

Company approved issue of 545,550 contingent shares to Hutano shareholders and 4,250,000 employee share options.

Additional Consideration Shares issued to Hutano shareholders 545,550
Employee share options awarded 4,250,000
Shares awarded to Martin Walton (director) 3,750,000
Total Ordinary Shares in issue 372,058,871

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your EDX notes

CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announces that the Company has approved the issue of the following ordinary shares.

545,55 new ordinary shares of 1p each ("Additional Consideration Shares") in the Company to 13 former shareholders (including employees) of Hutano Diagnostics Ltd, ("Hutano") a 100%-owned subsidiary of the Company since September 2023. The issue of these Additional Consideration Shares to the relevant Hutano shareholders is dependent on the achievement of certain commercial milestones, in this instance the successful passing of filing of a patent covering proprietary Point of Care testing technology.
4,250,000 ordinary shares under the 2024-25 Company employee performance-related share option scheme, of which 3,750,000 are awarded to Mr Martin Walton, a director and deputy chair of the Company, under a performance schedule.

On March 20, EDX Medical announced the issue of 21,428, 571 new ordinary shares as a result of an equity fundraising round. The total number of shares issued has been revised to 21, 428,568.

Total Voting Rights

The above figure of 372,058,871 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

The directors of EDX Medical accept responsibility for the contents of this announcement.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.